Lilly caps insulin price to $35 per month

April 7, 2020

Eli Lilly have announced that it will cap out-of-pocket costs for insulin to $35 per month to help diabetes patients across the United States as many face financial difficulties due to the coronavirus pandemic. Lilly recently had to assuage fears of insulin shortages.

The new co-pay scheme covers most of Lilly’s insulins, including widely-used Humalog injection, and can be availed by people with commercial insurance as well as those without insurance.

"Too many people in the U.S. have lost their jobs because of the COVID-19 crisis, and we want to make sure no one goes without their Lilly insulin," said Mike Mason, president, Lilly Diabetes. "We've been providing affordability solutions for a long time, but more is needed to help people during this unprecedented period.

Patients can get the Lilly Insulin Value Program card by calling the Lilly Diabetes Solution Center at 833-808-1234. The Solution Center is open 8 a.m. to 8 p.m. Eastern time, Monday through Friday.

Read the Eli Lilly release